To further investigate the possibility that TMPs expressing CD44 could be found in breast cancer patients following chemotherapy, we collected plasma samples from 15 breast cancer patients at baseline or 24 h after PTX chemotherapy administration. The gene discussed is CD44; the disease is breast cancer.